CNTA vs WFC · $6.15B cap vs P/E 15, $272.05B cap
Centessa Pharmaceuticals PLC ADR (CNTA) versus Wells Fargo & Company (WFC) — a side-by-side from cached financials, not a winner call.
Centessa Pharmaceuticals PLC ADR (CNTA) is a biotechnology company listed on US.
Wells Fargo & Company (WFC) is a banks - diversified company listed on US. It is led by Charlie Scharf.
Latest reported CNTA revenue for 2024-12-31 was $0. Net income was -$235.8M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. CNTA currently screens at market cap $6.15B.
WFC does not have a complete income-statement cache yet.
CNTA currently screens at market cap $6.15B. WFC currently screens at market cap $272.05B and trailing P/E 15.0.
Not investment advice. Open the CNTA and WFC stock pages for the full models.
Not investment advice.